Summary
- Current Price
- As of today, ALDX price is $1.46, up +8.96% on
- Current Price All-Time High
- ALDX price is currently -91.26% below its historical high of $16.70 set on
- Market Cap
- ALDX current market cap is $88M, down -72.79% year-over-year
- Revenue
- ALDX current annual revenue is $0.00, unchanged year-over-year
- Next Earnings
- The next earnings release for ALDX is on
Profile
| Metric | Value |
|---|---|
| Full Name | Aldeyra Therapeutics, Inc. |
| Ticker | NASDAQ: ALDX |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | aldeyra.com |
| Employees | 8 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| $1.46 | ||
| Price, 1D Change | +8.96% | |
| $88M | ||
| - | ||
| - | ||
| 1.28 | ||
| $0.00 | ||
| Revenue, 1Y Change | 0.00% | |
| -$0.56 | ||
| EPS, 1Y Change | +39.97% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| -$0.56 | ||
| EPS Estimate | -$0.34 | N/A |
| EPS Est. Change | +39.67% | N/A |
| $0.00 | ||
| Revenue Estimate | - | N/A |
| Revenue Est. Change | - | N/A |
| $1.46 | ||
| Price Target | $5.00 | - |
| Price Tgt. Change | +242.47% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$0.91 | -$0.94 | -2.86% | |
| -$0.60 | -$0.56 | +5.28% | |
| -$0.34 | N/A | +39.67% | |
| -$0.28 | N/A | +51.21% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| $24.25M | $0.00 | -100.00% | |
| - | N/A | - | |
| $6.72M | N/A | - |
🔒 Log In To Unlock Full Data
Performance
| Metric | Value | Date |
|---|---|---|
| -72.91% | ||
| -79.02% | ||
| -72.79% | ||
| -78.48% | ||
| 0.00% | ||
| 0.00% | ||
| +39.97% | ||
| +46.93% |
🔒 Log In To Unlock Full Data
Technicals
| Metric | Value | Date |
|---|---|---|
| $1.46 | ||
| $2.93 | ||
| $1.64 | ||
| $2.60 | ||
| $1.61 | ||
| -$0.05 | ||
| 1.28 | ||
| $0.09 | ||
| 44.42 | ||
| 70.82% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| $0.00 | ||
| -$0.56 | ||
| -$252.00K | ||
| - | ||
| -$35.27M | ||
| - | ||
| -$33.85M | ||
| - | ||
| -$35.01M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| 0.35 | ||
| 2.54 | ||
| 2.54 | ||
| - | ||
| - | ||
| -8.40 |
Valuations
| Metric | Value | Date |
|---|---|---|
| - | ||
| - | ||
| 2.32 | ||
| -1.81 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| $44.25M | ||
| $70.04M | ||
| $72.06M | ||
| $70.74M | ||
| $27.81M | ||
| $27.81M | ||
| $15.53M | ||
| $15.53M | ||
| $158.50K |
Expenses
| Metric | Value | Date |
|---|---|---|
| $33.85M | ||
| $35.01M | ||
| $252.00K | ||
| $0.00 | ||
| $252.00K | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| -$33.35M | ||
| $47.74M | ||
| $1.12M | ||
| $0.00 | ||
| -$33.35M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| HC Wainwright & Co. | → | |
| BTIG | → | |
| HC Wainwright & Co. | → | |
| BTIG | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| Oppenheimer | → | |
| HC Wainwright & Co. | → |
Analyst sentiment
Institutional ownership
Screeners with ALDX
FAQ
- What is the ticker symbol for Aldeyra Therapeutics, Inc.?
- The ticker symbol for Aldeyra Therapeutics, Inc. is NASDAQ:ALDX
- Does Aldeyra Therapeutics, Inc. pay dividends?
- No, Aldeyra Therapeutics, Inc. does not pay dividends
- What sector is Aldeyra Therapeutics, Inc. in?
- Aldeyra Therapeutics, Inc. is in the Healthcare sector
- What industry is Aldeyra Therapeutics, Inc. in?
- Aldeyra Therapeutics, Inc. is in the Biotechnology industry
- What country is Aldeyra Therapeutics, Inc. based in?
- Aldeyra Therapeutics, Inc. is headquartered in United States
- When did Aldeyra Therapeutics, Inc. go public?
- Aldeyra Therapeutics, Inc. initial public offering (IPO) was on May 2, 2014
- Is Aldeyra Therapeutics, Inc. in the S&P 500?
- No, Aldeyra Therapeutics, Inc. is not included in the S&P 500 index
- Is Aldeyra Therapeutics, Inc. in the NASDAQ 100?
- No, Aldeyra Therapeutics, Inc. is not included in the NASDAQ 100 index
- Is Aldeyra Therapeutics, Inc. in the Dow Jones?
- No, Aldeyra Therapeutics, Inc. is not included in the Dow Jones index
- When was Aldeyra Therapeutics, Inc. last earnings report?
- Aldeyra Therapeutics, Inc.'s most recent earnings report was on August 6, 2026
- When does Aldeyra Therapeutics, Inc. report earnings?
- The next expected earnings date for Aldeyra Therapeutics, Inc. is November 4, 2026
Data Sources & References
- ALDX Official Website www.aldeyra.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1341235/000119312526083012/0001193125-26-083012-index.htm
- ALDX Profile on Yahoo Finance finance.yahoo.com/quote/ALDX
- ALDX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/aldx